Differential induction of type I and III interferon genes in the upper respiratory tract of patients with coronavirus disease 2019 (COVID-19)
Carolina Scagnolari(Istituto Pasteur), Guido Antonelli(Policlinico Umberto I), Francesco Pugliese(Sapienza University of Rome), Laura Mazzuti(Istituto Pasteur), Gabriella d’Ettorre(Policlinico Umberto I), Federica Frasca(Sapienza University of Rome), Mirko Scordio(Sapienza University of Rome), Daniele Di Carlo(Istituto Pasteur), Giuseppe Oliveto(Sapienza University of Rome), Claudio Maria Mastroianni(Sapienza University of Rome), Giancarlo Ceccarelli(International Organization for Migration), Massimo Gentile(Istituto Pasteur), Angelo G. Solimini(Sapienza University of Rome), Camilla Bitossi(Istituto Pasteur), Agnese Viscido(Sapienza University of Rome), Alessandra Pierangeli(Policlinico Umberto I), Ombretta Turriziani(Sapienza University of Rome)
Cited by 34
Related Papers
Efficacy of Ceftazidime-Avibactam Salvage Therapy in Patients With Infections Caused by<i>Klebsiella pneumoniae</i>Carbapenemase–producing<i>K. pneumoniae</i>
|Clinical Infectious Diseases|2018|351
Post-Traumatic Stress Symptoms in Healthcare Workers Dealing with the COVID-19 Pandemic: A Systematic Review
|International Journal of Environmental Research and Public Health|2021|272
Ceftazidime-Avibactam Use for Klebsiella pneumoniae Carbapenemase–Producing <i>K. pneumoniae</i> Infections: A Retrospective Observational Multicenter Study
|Clinical Infectious Diseases|2021|264